Página 4 - Melhores Cancro do pâncreas médicos - TOP-128 médicos

O Prof. Klaus Kaczirek é um cirurgião endócrino e oncológico de destaque, especializado em tumores neuroendócrinos na Wiener Privatklinik.

• Mais de 30 anos de experiência em cirurgia endócrina
• Professor de Cirurgia na Universidade Médica de Viena
• Publicações extensas sobre biologia de tumores endócrinos e cirurgia minimamente invasiva
• Vice-chefe do Departamento de Cirurgia Geral do Hospital Geral de Viena

O Dr. Hossein Taghizadeh é especialista em cancros do pâncreas e das vias biliares, integrando terapias sistémicas modernas com cuidados personalizados na Wiener Privatklinik.

• Formado na Universidade de Medicina de Viena – uma das principais faculdades de medicina da Áustria
• Especialista em quimioterapia, terapia dirigida e imunoterapia para tumores gastrointestinais
• Focar em medicina baseada em evidências e apoio holístico ao paciente
• Trabalhar com ferramentas de diagnóstico avançadas para um planeamento de tratamento preciso

O Prof. Dr. med. Karl J. Oldhafer é um renomado especialista em cirurgia de cancro do pâncreas, fígado e estômago no Hospital Asklepios Barmbek.

• Consultor Sénior de Cirurgia Geral e Abdominal e Oncologia Cirúrgica
• Chefiar um centro de doenças hepáticas especializado em cirurgias complexas do fígado
• Utilizar técnicas avançadas como cirurgia hepática navegada por computador
• Trabalhar com equipas multidisciplinares, incluindo especialistas em oncologia e radiologia
• Especializar-se em técnicas de cirurgia abdominal minimamente invasiva

O Professor Associado Tahsin Ozatli é especialista no tratamento de cancros da mama, do pulmão e gastrointestinais no Hospital Universitário Istinye Liv.

• Experiência em várias clínicas de oncologia, incluindo hospitais públicos e de investigação
• Promovido a Professor Associado em 2016
• Formado em medicina pela Universidade Selcuk em Konya, Turquia

Formado em cirurgia laparoscópica avançada e bariátrica na Universidade de Istambul – líder em técnicas minimamente invasivas para cancro do pâncreas.

• Especialização em cirurgia laparoscópica desde 2002
• Formação avançada em cirurgia laparoscópica bariátrica e oncológica
• Educação nas principais instituições médicas turcas, incluindo a Universidade de Istambul

O Professor Gul Alco é especialista em rádio-oncologia para cancro do pâncreas na Universidade Medipol de Istambul.

• Mais de 20 anos de experiência em rádio-oncologia
• Especializar-se no tratamento do cancro do pâncreas
• Professor Associado e posteriormente Professor na Universidade Demiroglu Bilim
• Formação extensiva em rádio-oncologia

O Prof. Adjunto Nail Paksoy é especialista no tratamento do cancro do pâncreas no Hospital Medipol Bahçelievler, com base em extensa investigação e ensaios clínicos.

• Certificado pelo Conselho da ESMO em Oncologia Médica
• Subinvestigador em ensaios clínicos de cancro pancreático, incluindo RECITE – AMGEN
• Investigação publicada sobre FOLFIRINOX vs. Gemcitabina + Nab-Paclitaxel no Cancro do Pâncreas
• Formação especializada no Instituto de Oncologia da Universidade de Istambul

Especializada em viroterapia – uma das mais novas áreas da imunologia – a Dra. Jaunalksne traz mais de 30 anos de experiência para o tratamento do cancro do pâncreas.

• Chefiar o Centro de Imunologia Clínica do Hospital Clínico Universitário Pauls Stradins
• Licenciar-se no Instituto Médico de Riga com estágio em Medicina Interna
• Focar-se em abordagens imunológicas inovadoras para o cancro

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Especialista em cancro do pâncreas no Medical Park Antalya, formado no prestigiado programa de oncologia médica da Universidade de Akdeniz.

• Conclusão da especialização em oncologia médica em 2018
• Trabalhar no prestigiado complexo hospitalar Medical Park, em Antália
• Mais de 16 anos de experiência médica
• Cargos anteriores em hospitais universitários de ensino

O Dr. Ozden traz mais de 20 anos de experiência médica, especializando-se no tratamento do cancro do pâncreas no Hospital VM Medical Park Pendik.

• Licenciar-se na prestigiada Faculdade de Medicina Cerrahpaşa da Universidade de Istambul
• Concluir a subespecialidade de Oncologia Médica na Universidade de Kocaeli
• Ter vasta experiência em medicina interna antes de se especializar em oncologia

O Dr. Auala Hubert é chefe do Centro de Câncer Gastrointestinal do Hadassah Medical Center – um líder focado no tratamento de cancros do sistema digestivo, incluindo cancro do pâncreas.

• 33 anos de experiência especializada em oncologia e radioterapia
• Liderar um centro oncológico multidisciplinar num hospital universitário de topo
• Certificação médica em oncologia médica e radioterapia
• Membro ativo do Comité Nacional de Cancro Gastrointestinal
• Possuir dupla licenciatura em medicina e psicologia

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.